J. Thum

发表

Working capacity is increased following recombinant human erythropoietin treatment.

G. Mayer, H. Graf, H. Stummvoll, 1988, Kidney international.

Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures.

G. Mayer, H. Graf, W. Woloszczuk, 1988, American journal of nephrology.

Anaemia and reduced exercise capacity in patients on chronic haemodialysis.

G. Mayer, H. Graf, J. Thum, 1989, Clinical science.

Skin Oxygen Pressure Histograms in Patients with Peripheral Arterial Occlusive Disease During Intraarterial and Intravenous Prostaglandin E1 Infusions of Different Dosages and Their Prognostic Value

A. Creutzig, A. Arnold, K. Alexander, 1995, Angiology.

Decline in CD4+ cell numbers in cats with naturally acquired feline immunodeficiency virus infection

G. Hoffmann-Fezer, K. Hartmann, J. Mysliwietz, 1992, Journal of virology.

BLOOD PRESSURE AND ERYTHROPOIETIN

G. Mayer, J. Walls, H. Graf, 1988, The Lancet.

Development of autonomic dysfunction with intermittent hypoxia in a lean murine model

M. Khoo, C. O'Donnell, T. Yokoe, 2013, Respiratory Physiology & Neurobiology.

[Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].

G. Mayer, H. Graf, H. Stummvoll, 1987, Wiener klinische Wochenschrift.

Decline in CD 4 + Cell Numbers in Cats with Naturally Acquired Feline Immunodeficiency Virus Infection

G. Hoffmann-Fezer, K. Hartmann, J. Mysliwietz, 2022 .

Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.

A. Creutzig, K. Alexander, J. Thum, 1998, VASA. Zeitschrift fur Gefasskrankheiten.